Clinical Trial Update: Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-finding study evaluating a novel erythropoiesis-stimulating protein (NESP) for treating anemia in subjects with solid tumors receiving multicycle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Solid Tumors

Drugs mentioned

• NESP

Snippet

Sponsor: Amgen | Conditions: Anemia, Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED